Remove Biotechnology Remove Budget Remove CTO
article thumbnail

Biotech industry leaders share cautious optimism for 2023 amid downturn and layoffs

GeekWire

He’s now CEO of Nautilus Biotechnology, and he’s not taking any big chances in the current economic downturn. Everyone is budgeting 50% longer to raise their rounds,” said Canestaro. In Washington, Absci , Zymeworks , TwinStrand Biosciences , NanoString Technologies and Sana Biotechnology all shed employees in 2022.

Industry 101
article thumbnail

13 IT resolutions for 2024

CIO Business Intelligence

Bring the whole organization on the AI journey CIOs also see the need to bring everyone along on that AI journey, something that takes a well-articulated narrative about the benefits AI can bring to those who are and will be impacted by the technology. That’s the case for Yi Zhou, CTO and CIO with Adaptive Biotechnologies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Uncommon Thinkers: MagniX CTO Riona Armesmith geeks out over electric aviation

GeekWire

MagniX’s chief technology officer, Riona Armesmith, works on electric propulsion systems like the one in the background at the company’s headquarters in Everett, Wash. “It was a big program with a big budget, with a big partnership with Airbus and Siemens and various other suppliers,” she recalls.

article thumbnail

Juno’s lasting legacy: How the cell therapy juggernaut influenced biotech in Seattle and beyond

GeekWire

Juno veterans went on to start or fill leadership positions at Sana Biotechnology, Lyell Immunopharma, Umoja Biopharma, Shape Therapeutics, GentiBio, Eliem Therapeutics, Genemod, Century Therapeutics, Silverback Therapeutics, Tune Therapeutics, Affini-T Therapeutics, and others. Sana Biotechnology. Photo courtesy of William Canestaro).